Image pharmaphorum Editor News GSK's Nucala unlikely to get COPD use after panel vote FDA due to make decision in September News PureTech to research Alzheimer's drugs based on 'brain drain... US biotech PureTech Health is to develop therapies that are based on a new theory that neurological diseases such as Alzheimer’s are linked to drainage issues in the brain. News Philanthropists donate $30m towards finding Alzheimer’s cure A coalition of philanthropists has announced they are donating more than $30 million in a drive to combat Alzheimer’s disease. News NICE approves neuroblastoma immunotherapy drug for NHS use NICE has approved a drug to treat children with high-risk neuroblastoma within the NHS in England and Wales. Load more results
News PureTech to research Alzheimer's drugs based on 'brain drain... US biotech PureTech Health is to develop therapies that are based on a new theory that neurological diseases such as Alzheimer’s are linked to drainage issues in the brain.
News Philanthropists donate $30m towards finding Alzheimer’s cure A coalition of philanthropists has announced they are donating more than $30 million in a drive to combat Alzheimer’s disease.
News NICE approves neuroblastoma immunotherapy drug for NHS use NICE has approved a drug to treat children with high-risk neuroblastoma within the NHS in England and Wales.
News UK spurs prescribing of obesity jab Mounjaro with GP bonus Doctors in the UK will be given thousands of pounds in bonus payments from April for prescribing Eli Lilly's weight-loss drug Mounjaro.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
